John Longshore, PhD, FACMG, discusses selecting between comprehensive vs single-gene molecular testing in lung cancer.
John W. Longshore, PhD, Carolinas Pathology Group
Advertisement
Articles by John W. Longshore, PhD, Carolinas Pathology Group
John Longshore, PhD, FACMG, discusses key molecular markers in metastatic lung cancer.
Advertisement
Latest Updated Articles
Dr. Longshore on Key Molecular Markers in Metastatic Lung CancerMarch 10th 2021
Advertisement
Advertisement
Trending on OncLive
1
ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma
2
Dr Wainberg on INCB161734 Activity in Refractory Pancreatic Cancer
3
Peak Sets the Stage for Bezuclastinib/Sunitinib to Move Into the Advanced GIST Treatment Paradigm
4
Dr Pelster on the Rationale for Investigating Atebimetinib in Metastatic Pancreatic Cancer
5